Patents for A61P 17 - Drugs for dermatological disorders (106,455)
08/2009
08/20/2009US20090208504 Polypeptides involved in immune response
08/20/2009US20090208433 AH Receptor Antagonists
08/20/2009US20090208432 AH Receptor Antagonists
08/20/2009US20090208431 preparing a non-staining mixture by mixing a turmeric extract with an acidity berry extract in a ratio from 1:1 parts to 1:20 parts (v/v); for cosmetic, protective, and healing purposes without staining skin or clothing yellow
08/20/2009DE102008010579A1 Combination product obtained from a base mixture as main components, useful for the treatment of atopic dermatitis, comprises synthetic glucocorticoid, sage extract and suitable base
08/20/2009DE102008009929A1 3-(4-Hydroxy-3-methoxyphenyl)-1(4-hydroxphenyl)-1-propanon und deren Verwendung in kosmetischen und pharmazeutischen Zubereitungen 3- (4-hydroxy-3-methoxyphenyl) -1 (4-hydroxyphenyl) -1-propanone and their use in cosmetic and pharmaceutical preparations
08/20/2009DE102008009797A1 Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 3-(4-Hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-propan-1-on und Ethylhexyl-2-cyano-3,3-diphenylacrylat Cosmetic or dermatological preparations with a content of 3- (4-hydroxy-3-methoxyphenyl) -1- (4-hydroxyphenyl) -propan-1-one and ethylhexyl-2-cyano-3,3-diphenylacrylate
08/20/2009DE102008009758A1 Verwendung von 3-(4-Hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-propan-1-on zur verbesserten Hautkonturierung bzw. gegen Cellulite Using 3- (4-hydroxy-3-methoxyphenyl) -1- (4-hydroxyphenyl) -propan-1-one for improved Hautkonturierung or cellulite
08/20/2009DE102008009750A1 Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 3-(4-Hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-propan-1-on und einem oder mehreren Polyolen Cosmetic or dermatological preparations with a content of 3- (4-hydroxy-3-methoxyphenyl) -1- (4-hydroxyphenyl) -propan-1-one and one or more polyols
08/20/2009DE102008009749A1 Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 3-(4-Hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-propan-1-on und einem oder mehreren Zimtsäurederivaten Cosmetic or dermatological preparations with a content of 3- (4-hydroxy-3-methoxyphenyl) -1- (4-hydroxyphenyl) -propan-1-one and one or more cinnamic acid derivatives
08/20/2009DE102008009609A1 Substituierte 4-(Indol-3-yl)chinazoline und deren Verwendung und Herstellung Substituted 4- (indol-3-yl) quinazolines and their use and production
08/20/2009DE102006007831B4 Vernetztes Kohlehydratpolymer, insbesondere auf Basis von Polysacchariden und/oder Oligosacchariden und/oder Polyolen Cross-linked carbohydrate polymer, in particular based on polysaccharides and / or oligosaccharides and / or polyols
08/19/2009EP2090657A2 Anti-IL-12 antibodies, compositions, methods and uses
08/19/2009EP2090589A1 Albumin-fused Kunitz domain peptides
08/19/2009EP2090571A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation
08/19/2009EP2090316A1 Cosmetic and dermatological composition for psoriatic skin treatment
08/19/2009EP2090301A1 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanon und its use in cosmetic and pharmaceutical preparations
08/19/2009EP2090292A1 Means and methods for controlling commensales
08/19/2009EP2090285A1 Means and methods for controlling commensales
08/19/2009EP2089050A2 Il- 17b for use in wound healing
08/19/2009EP1971369B1 Combination of r,r-glycopyrrolate, rolipram and budesonide for the treatment of inflammatory diseases
08/19/2009EP1827465B1 Preparation made from diptera larvae for the treatment of wounds
08/19/2009EP1675603B1 Use of probiotic bacteria in the treatment of infection
08/19/2009EP1569672B1 Use of a centella asiatica extract rich in madecassoside and in terminoloside
08/19/2009EP1562621B1 Composition for treating ichthyosis using antitrypsin
08/19/2009EP1482973B1 Methods of modulating cd200 receptors
08/19/2009EP1463498B1 pharmaceutical COMPOSITION comprising a catechin, ascorbic acid, proline and lysine FOR THE TREATMENT OF NEOPLASTIC DISEASES
08/19/2009EP1414466B1 Combinations for the treatment of inflammatory disorders
08/19/2009EP1348706B1 Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
08/19/2009EP1255829B1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
08/19/2009CN101511819A N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
08/19/2009CN101511383A Use of WNT5A for inhibiting scarring
08/19/2009CN101511375A Methods of treating cancer and other conditions or disease states using l-cytosine nucleoside analogs
08/19/2009CN101511369A Methods and compositions for inhibiting angiogenesis.
08/19/2009CN101511350A Dioxo-alkanes and dioxo-alkenes
08/19/2009CN101508719A 11-deoxidized biogastrone acid-3-0-succinic acid half-ester rare earth salt and synthesis thereof
08/19/2009CN101507822A Reduction of dermal scarring
08/19/2009CN101507811A Wound healing agent and composition
08/19/2009CN101507805A Traditional Chinese medicine preparation capable of treating tache on face
08/19/2009CN101507797A Medicinal wine capable of treating alopecia
08/19/2009CN101507789A Xiao Bi Tang decoction capable of treating psoriasis and preparation method thereof
08/19/2009CN101507785A Ointment for treating psoriasis
08/19/2009CN101507781A Traditional Chinese medicine preparation capable of help hair growth
08/19/2009CN101507774A Traditional Chinese medicine for treating ichthyosis
08/19/2009CN101507773A Traditional Chinese medicine composite for treating eczema and preparation method thereof
08/19/2009CN101507771A Burn scald rehabilitation powder
08/19/2009CN101507759A Traditional Chinese medicine combination capable of preventing and treating seborrheic dermatitis and preparation and preparation method thereof
08/19/2009CN101507743A Biennial wormwood extract and preparation method thereof
08/19/2009CN101507736A Traditional Chinese medicine preparation for treating senile dementia, ischium lumbar, swollen glands, get-wind or the other rheumatism
08/19/2009CN101507733A Nano micromolecule hyaluronic acid and preparation method thereof
08/19/2009CN101507724A Use of pyrroloquinoline quinine in antiradiation
08/19/2009CN101507562A Production method of silk quilt with weight reduction and beautification function
08/19/2009CN100529759C Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
08/19/2009CN100529074C Therapeutic binding molecules
08/19/2009CN100528899C Fusion protein and nucleic acid containing peptide carrier and epidermal growth factor and its uses
08/19/2009CN100528850C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
08/19/2009CN100528847C Uv absorber compositions comprising a hydroxyphenyltriazine compound
08/19/2009CN100528231C Anti-inflammatory and antimicrobial uses for bioactive glass compositions
08/19/2009CN100528223C Skin collagen production promoter
08/19/2009CN100528217C Effective germinal liquid
08/19/2009CN100528203C Dragon's blood dropping pill and its preparing process
08/19/2009CN100528176C Chinese traditional medicinal composition for treating acne
08/19/2009CN100528165C Stable medicine composition of setastine or its salt
08/19/2009CN100528122C Cosmetic treatment of xerosis
08/18/2009US7576241 e.g. 2-hydroxy-5-methoxy-N-{2-[4-[(2-thienyl(imino)methyl)amino]phenyl]ethyl)}-benzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent
08/18/2009US7576204 (8E,12E,14E)-21-benzoyloxy-3,6-dihydroxy-6,10,12,16,20-pentamethyl-7-((4-methylpiperazin-1-yl)carbonyl)oxy-18,19-epoxytricosa-8,12,14-trien-11-olide; inhibits angiogenesis and inhibits the production of VEGF particularly under hypoxic conditions, which makes it useful as a remedy for solid cancer
08/18/2009US7576129 Carboxylic acid compounds
08/18/2009US7576125 Piperonyl alcohol; storage stability
08/18/2009US7576114 6-(4-Bromo-2-chloro-phenylamino)-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide; anticarcinogenic, antiproliferative, and antiinflammatory agents; mitogen-activated protein kinase inhibitors
08/18/2009US7576104 4-(Aminomethyl)-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione hydrochloride; cytokines level reduced; tumor necrosis factor inhibitors; nontoxic; anticarcinogenic agents; antitumor agents (solid/blood-borne); cardiovascular disorders; osteoporosis; antiinflammatory agents; autoimmune diseases
08/18/2009US7575879 Bone morpogenic proteins; endothelial growth factor e (vegfe); wound healing agents; bradycardial agents; identification and preparation of vascular endothelial growth factor-E (VEGF-E), a novel polypeptide related to vascular endothelial growth factor (VEGF) and bone morphogenetic protein 1
08/18/2009US7575741 Using interleukin-23 modulators to enhance wound healing
08/18/2009CA2577233C Pharmaceutical composition containing angiotensin ii antagonist
08/18/2009CA2505500C Method of stimulating hair growth using benzopyrans
08/18/2009CA2481591C Stabilized ascorbic acid derivatives
08/18/2009CA2412208C Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators
08/18/2009CA2375865C Treatment and analysis of proliferative disorders
08/18/2009CA2224150C Use of locally applied dna fragments
08/18/2009CA2174526C Pseudodipeptide product possessing an imidazole group and the therapeutic, cosmetological and agri-food applications of the said product
08/17/2009CA2709732A1 Lower dosage strength imiquimod formulations and short dosing regimens for treating actinic keratosis
08/13/2009WO2009099890A2 Methods of treating skin with aromatic skin-active ingredients
08/13/2009WO2009099195A1 Skin whitening agent and external preparation for the skin
08/13/2009WO2009099194A1 Skin whitening agent and external preparation for the skin
08/13/2009WO2009099193A1 Skin whitening agent and external preparation for the skin
08/13/2009WO2009099192A1 Skin whitening agent and external preparation for the skin
08/13/2009WO2009099086A1 3-substituted sulfonyl piperazine derivative
08/13/2009WO2009098649A1 Immunosuppressive macrolide powder for oral suspension
08/13/2009WO2009098320A2 Macrolides for treating diseases mediated through pde inhibition
08/13/2009WO2009098127A1 Biocompatible injectable products with zinc and/or zinc-form saccharide-salt release, and uses thereof
08/13/2009WO2009077635A3 Anti-inflammatory, anti-edematous and anti-erythematous composition, method for obtaining same and use thereof
08/13/2009WO2009056754A3 Use of econazole or salts thereof for treating acne
08/13/2009WO2009043525A3 Use of the combination of gluten exorphin c and cd36 as a therapeutic agent
08/13/2009WO2009043453A3 Use of a peptide as a therapeutic agent
08/13/2009US20090204187 Soil-based compositions and methods for removal of toxins from mammals
08/13/2009US20090203779 Esters of long-chain alcohols and preparation thereof
08/13/2009US20090203767 Inhibition stat-1
08/13/2009US20090203760 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS
08/13/2009US20090203751 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
08/13/2009US20090203739 Anti-Inflammatory Agents
08/13/2009US20090203734 F1f0-atpase inhibitors and related methods